Targeted sphingolipid metabolism for treatment of AML

Ended Project Grant Awarded Last action

Award ID
P01CA171983
Recipient
Awarding agency
Obligated
$29,681,855

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Funding
  • $27,686,376.00 Federal
  • $1,995,479.00 Non-federal
Place of performance
Virginia, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,894,532 $0
Amendment $1,894,532 $0
Amendment $1,954,358 $0
Amendment $1,954,358 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,954,358 $0
Amendment $1,954,358 $0
Amendment $1,995,479 $0
Amendment $1,995,479 $1,995,479
Amendment $7,209 $0
Amendment $2,054,089 $0
Amendment -$7,209 $0
Amendment $2,019,502 $0
Amendment $2,019,502 $0
Amendment $2,077,502 $0
Amendment $1,929,328 $0
Original award $1,988,999 $0
Show all 23

Subawards

Subrecipient Amount Awarded
University Of Arizona As Co-Investigator/Consortium Principal Investigator, Dr. Date will prepare SACLAC conjugates and/or nanoformulations and ship them to the University of… $19,000
Wake Forest University Health Sciences Dr. Fisher-Wellman is an eminent expert in mitochondrial function, who has been working with Dr. Myles Cabot and the rest of the P01 team for the past several… $159,600
East Carolina University Targeted Sphingolipid Metabolism for Treatment of AML - PROJECT SUMMARY Through three inter-related and inter-dependent Projects and four essential Cores, our… $108,000
University Of Alaska Southeast Dr. Barth will work to better understand how sphingolipid metabolism in acute myeloid leukemia (AML) and related hematological disorders governs sensitivity… $43,875
University Of Arizona As Co-Investigator/Consortium Principal Investigator, Dr. Date will prepare SACLAC nanoemulsions and ship them to PTE to enable smooth conduction of… $20,000
Sloan-Kettering Institute For Cancer Research MSKCC provides de-identified molecularly phenotypes AML patient cells to the team for sphingolipid profiling. They are also a site for the CAV clinical trial. $701,184
The Pennsylvania State University Penn State University continues to be the major site for our clinical AML repository and animal testing facility. Led by Dr. Claxton, the team is responsible… $1,605,625

Quick answers

Who received award P01CA171983?

P01CA171983 was awarded to Rector & Visitors Of The University Of Virginia by National Cancer Institute (National Institutes of Health) on September 10, 2013.

How much is award P01CA171983 worth?

$29,681,855 has been obligated on P01CA171983: $27,686,376 in federal funding and $1,995,479 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login